GARLAND JASON K (CFO) sold 3.6% of their position (733.00 shares) of REPLIGEN CORP on the open market
Open‑market sale worth $106.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/26/2026ACC: 0001193125-26-285449
-733.00
Net shares
Net seller
$106.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
733.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−733.00
Price / share
$145.00
Trade value
$106.28K
% of position
3.6%
6/25/2026
20.09K→19.36K
Total
Net shares
−733.00
Net value
-$106.28K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/25/2026 | S · Sale | −733.00 | $145.00 | $106.28K | 3.6% | 20.09K | 19.36K |
| Total | −733.00 | -$106.28K | ||||||
Derivative Transactions0
No derivative transactions reported